XTL Biopharma Stock Price (NASDAQ:XTLB)

Add to My Stocks
$1.84 $0.09 (5.14%) XTLB stock closing price Sep 18, 2018 (Closing)
Prev Close* : $1.75
Market Cap:
$23.99M
Day Low: $1.84
52 Week Low: $1.55
Open: $1.92
Volume: -
Day High: $1.92
52 Week High: $3.94
Dividend:
0.00

Latest Stock Market News

Latest Articles

XTLB Stockcharts

View XTLB PE ratio, PS ratio stocks charts and compare with peers.
XTLB Chart
Note: Compare XTL Biopharma stock price history with the index and industry peers.

XTL Biopharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

XTL Biopharma Returns

ROE
(return on equity)
-

XTL Biopharma Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

XTLB Industry Peers

Company Price Change (%)
Xenetic Biosciences (XBIO)2.410.17 (6.59%)
Neurovive (NEVPF)0.460.01 (2.22%)
Can-fite Biopharma (CANF)1.330.05 (3.91%)
Celgene (CELG)87.610.41 (0.47%)
Bristol-myers Squibb (BMY)61.480.18 (0.29%)
Novartis (NVS)85.030.1 (0.12%)
Merck (MRK)70.420 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

X T L Biopharmaceuticals Ltd (ADR) Stock News - Partner Headlines

XTL Biopharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues----2.36M
Net Income-0.78M-2.54M-4.31M-2.11M-3.71M
Total Operating Expense1.2M1.27M3.02M1.74M3.73M
View XTL Biopharma income statement
balance sheet20172016201520142013
Total Assets6.58M3.01M5.32M5.64M8.01M
Total Liabilities2.96M---1.23M
Shareholders Equity3.61M2.68M4.88M4.67M6.78M
View XTL Biopharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--0.22M-0.01M-1.21M
Net Cash from (used by) Operating Activities-1.12M-1.73M-1.86M-2.47M-2.49M
Increase (Decrease) in Prop Plant And Equipment----0.01M-0.08M
View XTL Biopharma cash flow statement

XTL Biopharma Stock Message Board

As of last trading day, XTL Biopharma stock price was $1.84. Stock price or share price can be used to find the total market value of a company. XTL Biopharma market cap stands at $23.99M as of Sep 18, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing XTL Biopharma stock analysis.

The terms stocks and shares mean the same thing. For Ex: XTL Biopharma stock price and XTL Biopharma share price mean the same thing. 1,356 shares were traded with a closing stock price of $1.84 as of Sep 18, 2018, as can be seen from XTL Biopharma stock quote. One can view XTL Biopharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. XTL Biopharma does not pay dividends. One can observe stock price trends and check for volatility by checking XTL Biopharma stock price history.